Philippe Houyau

机构：Clinique Claude-Bernard

发表论文 13 篇 · 总被引 381 次 · h-index 8

代表论文

• 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial (2019 · The Lancet · 被引 129)
• Severe Fluorouracil Toxicity in a Patient With Dihydropyrimidine Dehydrogenase Deficiency (1993 · JNCI Journal of the National Cancer Institute · 被引 58)
• Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial. (1998 · Journal of Clinical Oncology · 被引 53)
• Phase II study of vinorelbine in patients with androgen-independent prostate cancer (2001 · Annals of Oncology · 被引 46)
• FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial. (2016 · Journal of Clinical Oncology · 被引 22)
• Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX) (2020 · European Journal of Cancer · 被引 19)